Swine Japanese Encephalitis Vaccine, Live

• Customization: Available
• Varieties: Vaccine
• Component: Virus
• Model NO.: SA14-14-2 Strain
• Pharmacodynamic Influential Factors: Virus
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: 154391068
• Usage: Administer Via Intramuscular Injection in The Neck
• Shelf Life: 18 Months
• Temperature: Store at -15ºC
• Withdrawal Period: 0 Day
• Package: 700 Bottles / Carton
• Transport Package: Air Way/Sea Way
• Specification: 10 dose/vial
• Trademark: SINDER
• Origin: China
• Production Capacity: 100000L/Year
• Package Size: 61.20cm * 34.50cm * 41.00cm
• Package Gross Weight: 20.000kg

Product Description

Product Description

GENERIC NAME:
Swine Japanese Encephalitis Vaccine, Live (SA14-14-2 Strain).
COMPOSITION:
This product contains the Swine Japanese Encephalitis Virus (SA14-14-2 Strain), the virus content of each dose ≥ 10^5.7TCID₅₀.
CHARACTERISTIC:
The product presents as sponge-like loose clumps that easily disengage from the bottle wall, and rapid dissolution in the PBS.
INDICATION(S):
The product is used for the prevention of Porcine Japanese Encephalitis. The immunity period is 12 months.
ADMINISTRATION AND DOSAGE:
Administered through intramuscular injection. Dilute according to the label using a specific diluent to achieve a concentration of 1.0m per dose. Administer 1.0ml per pig. For replacement breeding sows and boars aged 6-7 months, administer 1.0ml via intramuscular injection 20-30 days before mating, and then one more booster administration annually in spring. For lactating sows and adult breeding boars, administer 1.0ml via intramuscular injection annually in spring. In areas where Japanese encephalitis is prevalent, piglets and other pig populations should also be vaccinated.
SPECIAL WARNING IF NECESSARY: 

1. The vaccine must be stored and transported under refrigeration conditions.
2. The vaccine should be prepared and used immediately. It is advisable to pre-chill the diluent at 2-8°C before use.
3. It is recommended to administer the vaccine in the months of April to May (before the breeding season of mosquitoes and flies).
4. Pigs selected for vaccination should be in good health and free from diseases. The injection equipment must undergo strict disinfection.
5. Used vaccine bottles, equipment, and any unused vaccines should be disposed of in an environmentally safe manner.

Swine Japanese Encephalitis Vaccine, Live (SA14-14-2 Strain)
(1) Long time encephalitis vaccine manufacturing experience ensures the qulity of the product.
(2) High purification for the virus strain with high stability.

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.